| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0166-6851(03)00160-9 |
| P698 | PubMed publication ID | 12946842 |
| P50 | author | Armando Isibasi | Q46151584 |
| P2093 | author name string | Ingeborg Becker | |
| Nallely Cabrera | |||
| Armando Isibasi | |||
| Adriana Ruiz | |||
| Carmen Maldonado | |||
| Norma Salaiza | |||
| Nuria Carrillo-Carrasco | |||
| Armando Pérez Torres | |||
| Augusto González | |||
| José Delgado | |||
| Laila Gutiérrez Kobeh | |||
| Magdalena Aguirre | |||
| Rocely Cervantes | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes | Q28141639 | ||
| Innate immunity: the virtues of a nonclonal system of recognition | Q29614428 | ||
| Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity | Q33754727 | ||
| Turning on natural killer cells | Q33894477 | ||
| Perforin: more than just an effector molecule | Q33926434 | ||
| Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis. | Q34129088 | ||
| Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor | Q34377405 | ||
| Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion. | Q35498914 | ||
| The lipophosphoglycan of Leishmania parasites | Q35534721 | ||
| Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice | Q36366305 | ||
| Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes | Q36752141 | ||
| Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequence | Q37049671 | ||
| The role of phosphoglycans in Leishmania-sand fly interactions | Q37155066 | ||
| Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages | Q37306214 | ||
| The role of natural killer cells in host-parasite interactions | Q40540042 | ||
| Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma. | Q40668224 | ||
| Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite | Q40797228 | ||
| The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes | Q40847001 | ||
| Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. | Q40858293 | ||
| Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide | Q40990203 | ||
| Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan | Q41104354 | ||
| Innate immunity: impact on the adaptive immune response | Q41353080 | ||
| Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species | Q42822016 | ||
| Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes | Q44879905 | ||
| Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells | Q45345615 | ||
| Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis. | Q52240329 | ||
| Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. | Q54017251 | ||
| Early parasite containment is decisive for resistance to Leishmania major infection. | Q54166265 | ||
| Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells. | Q54225795 | ||
| Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells | Q58857522 | ||
| Human NK-cell receptors | Q61719167 | ||
| Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction | Q70587013 | ||
| Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis | Q71071269 | ||
| Cytotoxicity in human mucosal and cutaneous leishmaniasis | Q72194529 | ||
| Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection | Q73209290 | ||
| Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome | Q73348752 | ||
| Leishmania virulence: it's a knock out! | Q73562459 | ||
| Requirement for type 2 NO synthase for IL-12 signaling in innate immunity | Q77730607 | ||
| Exploitation of the complement system by Leishmania promastigotes | Q80381502 | ||
| P433 | issue | 2 | |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 65-74 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Molecular and Biochemical Parasitology | Q15752756 |
| P1476 | title | Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. | |
| P478 | volume | 130 |
| Q52940660 | A critical role for lipophosphoglycan in proinflammatory responses of dendritic cells to Leishmania mexicana. |
| Q38319439 | Activation of natural killer-like YT-INDY cells by oligodeoxynucleotides and binding by homologous pattern recognition proteins |
| Q33838940 | Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells |
| Q91971683 | An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More |
| Q46244701 | An overview on Leishmania (Mundinia) enriettii: biology, immunopathology, LRV and extracellular vesicles during the host-parasite interaction |
| Q44805980 | Analysis of the expression of toll-like receptors 2 and 4 and cytokine production during experimental Leishmania chagasi infection. |
| Q42216402 | Anti-Toll-like receptor 2 and 4 antibodies suppress inflammatory response in mice. |
| Q37177598 | Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications |
| Q37429219 | Bovine natural killer cells |
| Q36881887 | Brief Exercise Increases Peripheral Blood NK Cell Counts without Immediate Functional Changes, but Impairs their Responses to ex vivo Stimulation |
| Q33745224 | CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. |
| Q37016265 | CD8 cytotoxic T cells in cutaneous leishmaniasis |
| Q61800023 | Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis |
| Q37521995 | Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major |
| Q35571431 | Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice. |
| Q54624804 | Cystatin cures visceral leishmaniasis by NF-κB-mediated proinflammatory response through co-ordination of TLR/MyD88 signaling with p105-Tpl2-ERK pathway. |
| Q46270906 | Cytotoxic activity in cutaneous leishmaniasis |
| Q64926521 | Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis. |
| Q35859111 | Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells |
| Q30389411 | Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses |
| Q42085198 | Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. |
| Q34282214 | Disease severity in patients infected with Leishmania mexicana relates to IL-1β. |
| Q48932895 | Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists |
| Q37256528 | Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice |
| Q38266457 | Do you see what I see: Recognition of protozoan parasites by Toll-like receptors |
| Q90608419 | Dog hepatocytes are key effector cells in the liver innate immune response to Leishmania infantum |
| Q43168661 | Dog skin parasite load, TLR-2, IL-10 and TNF-α expression and infectiousness. |
| Q35975567 | Down-Regulation of TLR and JAK/STAT Pathway Genes Is Associated with Diffuse Cutaneous Leishmaniasis: A Gene Expression Analysis in NK Cells from Patients Infected with Leishmania mexicana |
| Q33741807 | Dual effect of Plasmodium-infected erythrocytes on dendritic cell maturation. |
| Q36077527 | Entamoeba histolytica Trophozoites and Lipopeptidophosphoglycan Trigger Human Neutrophil Extracellular Traps |
| Q58856710 | Expression and function of Toll-like receptor 2 in canine blood phagocytes |
| Q54308043 | Expression of TLR2 and TLR4 in lesions of patients with tegumentary American leishmaniasis. |
| Q90280661 | Expression of TLR2, TLR3, TLR4, and TLR7 on pulmonary lymphocytes of Schistosoma japonicum-infected C57BL/6 mice |
| Q34719048 | Expression of Toll-like receptors 2 and 9 in cells of dog jejunum and colon naturally infected with Leishmania infantum. |
| Q34025104 | FimH can directly activate human and murine natural killer cells via TLR4 |
| Q40564843 | Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin |
| Q35740567 | Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species |
| Q34184759 | Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: modulation of innate immune system and variations in carbohydrate structure |
| Q36381044 | HBD-3 induces NK cell activation, IFN-γ secretion and mDC dependent cytolytic function |
| Q35126397 | HMGB1-promoted and TLR2/4-dependent NK cell maturation and activation take part in rotavirus-induced murine biliary atresia |
| Q35903321 | Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection |
| Q43920033 | Histopathological analysis of initial cellular response in TLR-2 deficient mice experimentally infected by Leishmania (L.) amazonensis. |
| Q39113003 | Host cell signalling and leishmania mechanisms of evasion. |
| Q52401290 | How to master the host immune system? Leishmania parasites have the solutions! |
| Q37798456 | Human immunodeficiency virus and leishmaniasis |
| Q34474604 | Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response |
| Q34017578 | IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo. |
| Q36593757 | Immune privilege in sites of chronic infection: Leishmania and regulatory T cells |
| Q36915063 | Immune response regulation by leishmania secreted and nonsecreted antigens |
| Q38794791 | Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors |
| Q37770420 | Immunological perspectives of leishmaniasis |
| Q36610873 | Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells |
| Q64070738 | Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis |
| Q49479299 | Infection of Human Monocytes with Leishmania infantum Strains Induces a Downmodulated Response when Compared with Infection with Leishmania braziliensis |
| Q34043775 | Inflammasomes in host response to protozoan parasites. |
| Q37811555 | Innate Immunity and Leishmania Vaccination Strategies |
| Q38004492 | Innate immune activation and subversion of Mammalian functions by leishmania lipophosphoglycan. |
| Q27010187 | Innate immunity against Leishmania infections |
| Q37605215 | Insights on adaptive and innate immunity in canine leishmaniosis |
| Q58283211 | Interferon-gamma secretion is induced in IL-12 stimulated human NK cells by recognition of Helicobacter pylori or TLR2 ligands |
| Q92242832 | Intraspecies Polymorphisms in the Lipophosphoglycan of L. braziliensis Differentially Modulate Macrophage Activation via TLR4 |
| Q41889334 | Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cells |
| Q51544796 | Leishmania (Viannia) braziliensis: insights on subcellular distribution and biochemical properties of heparin-binding proteins. |
| Q90414581 | Leishmania donovani induced Unfolded Protein Response delays host cell apoptosis in PERK dependent manner |
| Q39942052 | Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism |
| Q38873769 | Leishmania donovani influenced cytokines and Toll-like receptors expression among Sudanese visceral leishmaniasis patients |
| Q37363354 | Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival |
| Q35030191 | Leishmania enriettii: biochemical characterisation of lipophosphoglycans (LPGs) and glycoinositolphospholipids (GIPLs) and infectivity to Cavia porcellus |
| Q43562457 | Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses |
| Q55238577 | Leishmania infantum Lipophosphoglycan-Deficient Mutants: A Tool to Study Host Cell-Parasite Interplay. |
| Q47131860 | Leishmania infantum lipophosphoglycan induced-Prostaglandin E2 production in association with PPAR-γ expression via activation of Toll like receptors-1 and 2. |
| Q33781265 | Leishmania interferes with host cell signaling to devise a survival strategy |
| Q34992273 | Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate? |
| Q46879707 | Leishmania major : detection of membrane-bound protein tyrosine phosphatase |
| Q39543850 | Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease |
| Q37426817 | Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: involvement in cytokine synthesis |
| Q46933779 | Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4. |
| Q38435511 | Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression |
| Q36593911 | Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4. |
| Q35986637 | Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts |
| Q53538133 | Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response. |
| Q37999956 | Leishmaniasis: vaccine candidates and perspectives |
| Q28553439 | Lipophosphoglycans from Leishmania amazonensis Strains Display Immunomodulatory Properties via TLR4 and Do Not Affect Sand Fly Infection |
| Q36566599 | Lipopolysaccharide induces IFN-γ production in human NK cells. |
| Q58608734 | Lipopopeptidephosphoglycan from Entamoeba histolytica activates human macrophages and dendritic cells and reaches their late endosomes |
| Q35685422 | Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. |
| Q89590514 | MicroRNA exporter HuR clears the internalized pathogens by promoting pro-inflammatory response in infected macrophages |
| Q37702795 | Modulation of dendritic cell responses by parasites: a common strategy to survive |
| Q64110626 | Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View |
| Q37046858 | Monarch-1 Activation in Murine Macrophage Cell Line (J774 A.1) Infected with Iranian Strain of Leishmania major |
| Q50329879 | Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to Leishmania Parasites. |
| Q34789819 | Monocytes play an IL-12-dependent crucial role in driving cord blood NK cells to produce IFN-g in response to Trypanosoma cruzi |
| Q59136686 | More than just exosomes: distinct extracellular products potentiate the establishment of infection |
| Q49164976 | NK Cells and Their Role in Invasive Mold Infection |
| Q36229299 | NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. |
| Q34513470 | NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines |
| Q40048369 | NKp30 ligation induces rapid activation of the canonical NF-kappaB pathway in NK cells |
| Q37959322 | Natural killer (NK) cells in antibacterial innate immunity: angels or devils? |
| Q33444653 | Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess |
| Q37860087 | Natural killer cell activation secondary to innate pattern sensing |
| Q37853786 | Natural killer cell responses to infections in early life. |
| Q36757854 | Natural killer cells and antifungal host response. |
| Q38037557 | Natural killer cells in experimental and human leishmaniasis |
| Q42951271 | Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania major. |
| Q38246728 | Natural killer cells: a coherent model for their functional role in Mycobacterium tuberculosis infection. |
| Q36955475 | Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity |
| Q35641142 | Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-gamma |
| Q90649263 | Overview of the role of kinetoplastid surface carbohydrates in infection and host cell invasion: prospects for therapeutic intervention |
| Q53825890 | Parasite Specific Antibody Levels, Interferon-γ and TLR2 and TLR4 Transcripts in Blood from Dogs with Different Clinical Stages of Leishmaniosis. |
| Q35672857 | Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil |
| Q44993630 | Potent induction of IFN-γ production from cord blood NK cells by the stimulation with single-stranded RNA. |
| Q43243071 | Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus |
| Q40309220 | Production of nitric oxide by murine macrophages induced by lipophosphoglycan of Leishmania major |
| Q36655907 | Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. |
| Q36372539 | Putting the natural killer cell in its place. |
| Q40337463 | RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages |
| Q36279154 | Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity |
| Q41105296 | Recombinant Leishmania major lipophosphoglycan 3 activates human T-lymphocytes via TLR2-independent pathway |
| Q39435029 | Redundant and regulatory roles for Toll-like receptors in Leishmania infection. |
| Q60046657 | Relationship of peripheral blood mononuclear cells miRNA expression and parasitic load in canine visceral leishmaniasis |
| Q47316811 | Resistance to apoptosis in Leishmania infantum-infected human macrophages: a critical role for anti-apoptotic Bcl-2 protein and cellular IAP1/2. |
| Q97529520 | Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection |
| Q37028880 | Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria. |
| Q36950033 | Role of natural killer cells in modulating dendritic cell responses to Leishmania amazonensis infection |
| Q35884180 | Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. |
| Q37299969 | Signaling networks in Leishmania macrophages deciphered through integrated systems biology: a mathematical modeling approach |
| Q36357683 | Sirtuins of parasitic protozoa: in search of function(s). |
| Q50617681 | Synthesis of a Glycosylphosphatidylinositol Anchor Derived from Leishmania donovani That Can Be Functionalized by Cu-Catalyzed Azide-Alkyne Cycloadditions. |
| Q90305577 | Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis |
| Q38173691 | TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals |
| Q38200088 | TLR/NCR/KIR: Which One to Use and When? |
| Q46070025 | TLR2 and TLR4 in cutaneous leishmaniasis caused by Leishmania major |
| Q35565170 | TLR2 mediates immunity to experimental cysticercosis. |
| Q40329762 | Th17 cells and neutrophils: Close collaborators in chronic Leishmania mexicana infections leading to disease severity |
| Q43937173 | The MyD88 protein 88 pathway is differently involved in immune responses induced by distinct substrains of Leishmania major. |
| Q46264450 | The NOD2 receptor is crucial for immune responses towards New World Leishmania species |
| Q36599857 | The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models. |
| Q54453675 | The contribution of Toll-like receptor 2 to the innate recognition of a Leishmania infantum silent information regulator 2 protein. |
| Q46623619 | The genetically determined production of the alarmin eosinophil-derived neurotoxin is reduced in visceral leishmaniasis |
| Q40418682 | The innate immune response to Entamoeba histolytica lipopeptidophosphoglycan is mediated by toll-like receptors 2 and 4. |
| Q39179238 | The interplay between Leishmania promastigotes and human Natural Killer cells in vitro leads to direct lysis of Leishmania by NK cells and modulation of NK cell activity by Leishmania promastigotes. |
| Q35112512 | The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs |
| Q84289753 | The involvement of TLR2 in cytokine and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major phosphoglycans (PGs) |
| Q34334173 | The protozoan Neospora caninum directly triggers bovine NK cells to produce gamma interferon and to kill infected fibroblasts |
| Q33633292 | The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica |
| Q34091014 | Toll receptors type-2 and CR3 expression of canine monocytes and its correlation with immunohistochemistry and xenodiagnosis in visceral leishmaniasis |
| Q37660791 | Toll-Like Receptor 2 Is Required for Inflammatory Process Development during Leishmania infantum Infection. |
| Q59800406 | Toll-Like Receptor and miRNA-let-7e Expression Alter the Inflammatory Response in Leishmania amazonensis-Infected Macrophages |
| Q34143804 | Toll-Like Receptors, Tissue Injury, and Tumourigenesis |
| Q28822416 | Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan |
| Q54288276 | Toll-like receptor 4 (TLR4) polymorphisms in Iranian patients with visceral leishmaniasis. |
| Q38432017 | Toll-like receptor signaling in parasitic infections. |
| Q54255382 | Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis. |
| Q36483521 | Toll-like receptors and leishmaniasis. |
| Q37809550 | Toll-like receptors and their adapter molecules |
| Q36928269 | Toll-like receptors expression and interferon-γ production by NK cells in human sepsis |
| Q38004493 | Toll-like receptors in leishmania infections: guardians or promoters? |
| Q38686877 | Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis |
| Q33707467 | Trypanosomiasis-induced Th17-like immune responses in carp. |
| Q36710445 | Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages |
| Q36666215 | UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major |
| Q87162642 | Vaccination with Leishmania mexicana LPG induces PD-1 in CD8⁺ and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy |
| Q80809469 | Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice |
| Q43801603 | Virulence loss and amastigote transformation failure determine host cell responses to Leishmania mexicana |
| Q36767499 | Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens |
Search more.